| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |